Status epilepticus treatment remains 'too low, too slow.' Combining benzodiazepines with NMDA receptor blockers like ketamine early on can dramatically improve outcomes and prevent brain injury.
https://t.co/MTA07oJY6f
#epilepsy
Gibson et al. analysed postmortem brains from over 7000 older adults. Lewy body pathology was present in more than one in four people, with anatomical distributions of pathology differing by sex and showing distinct associations with co-pathologies. https://t.co/8QBvkC1GnU
💬 Editorial by Jeffrey L. Saver, MD: In #AcuteIschemicStroke, reperfusion therapies now reopen most occluded arteries, but many patients still have disabling outcomes after treatment.
The LAIS trial indicates that loberamisal may improve 3-month disability-free recovery in patients who were not eligible for endovascular thrombectomy, supporting continued evaluation of #Neuroprotection alongside reperfusion strategies.
https://t.co/rJNCKFPWOy
🔥Hot off the press for #ACR26 🔥
The @IgG4ward foundation guidelines on the treatment of IgG4-related disease
https://t.co/B3NKHxDKzK
Free to read on https://t.co/gt6JPgLHUG
We published the first imaging marker to diagnose primary CNS vasculitis (PCNSV). The presence of cerebellar tonsillar hemorrhages, particularly when accompanied by punctate/linear enhancement, is suggestive of PCNSV #PCNSV#PACNS@FrontImmunol
Link: 10.3389/fimmu.2026.1961925
📊 Research Summary: For adults with acute #ischemicstroke presenting 4.5 to 24 hours after symptom onset, the addition of intravenous #tenecteplase before EVT did not improve 90-day clinical outcomes and showed no significant difference in safety compared with EVT alone.
https://t.co/7R5UUCivu2
Freezing of gait can be difficult to capture—and even harder to treat.
John B. Sanderson, MD, reviews wearable sensing, adaptive cueing, and #neuromodulation technologies being studied in #ParkinsonDisease.
https://t.co/5XGYdTYwbi
@movedisorder@UW#MedTech
Our featured article for November - Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions. Read it in full for free here: https://t.co/j7qfdvVaZ6 #SharedIt
General neurology is the foundation of every neurology supra-specialty!🧠
This superb review in @GreenJournal by @SanRaffaeleMI is a great chance to brush up on cranial neuropathies, with practical algorithms and clinical pearls.
This is what clinical reviews should be: clinically focused and practical, going beyond a narrative summary of the literature that AI could write!
👉🏼https://t.co/RzwSiJXGEj
#Neurology #NeuroTwitter
The discovery of 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 has advanced the prevention and treatment of gastritis, peptic ulcers, and gastric cancer. Progress has been made in the research of 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection. These advances are discussed in a new review.
Read the Review Article “𝘏𝘦𝘭𝘪𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘱𝘺𝘭𝘰𝘳𝘪 Infection — Advances, Challenges, and the Road Ahead” by Hong Li, MD, PhD, Francis Megraud, MD, and Barry J. Marshall, MD: https://t.co/rMlsoi2ATy
The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy https://t.co/XxiOeEyTtt
📊 Among older adults, current smoking, #Hypertension, #Diabetes, chronic kidney disease, and history of stroke were associated with higher risk of #LateOnsetEpilepsy, indicating a link with underlying vascular disease.
https://t.co/znlvUUCwBi
Could obesity be quietly aging our brains and increasing our risk of dementia? Obesity refers to excess body fat that can negatively affect health, including brain health. Cali McEntee, Eva Feldman and colleagues describe in a new review in Nature Reviews Neurology how obesity may affect memory, thinking and the biological pathways involved in dementia.
Key points:
- Midlife obesity is associated w/ cognitive decline and an increased risk of dementia, even when weight decreases later in life.
- Obesity may affect the hippocampus and prefrontal cortex, brain regions essential for memory, attention and decision-making, through inflammation, insulin resistance and vascular dysfunction.
- Exercise, healthier nutrition, weight-loss surgery and newer weight-management medications offer potential opportunities to improve metabolic health and possibly protect cognition, although more definitive trials are needed.
My take: What resonates w/ me is that obesity is not simply a number on a scale. It is a biological condition that can influence how our brains function and age. The brain and body are not separate universes. Inflammation, blood vessel health, insulin signaling and metabolism all matter. Perhaps most importantly, the timing of obesity matters. Carrying excess weight in midlife may have consequences that are not completely reversed by losing weight decades later.
Here are 5 points that resonated w/ me:
1- Midlife may represent an important window of opportunity for protecting long-term brain health.
2- Where fat accumulates may matter as much as how much we weigh, particularly when it collects around the abdomen.
3- Obesity can create a vicious cycle in which inflammation disrupts the brain circuits controlling appetite, potentially promoting further weight gain.
4- Exercise, nutrition and appropriate medical treatment should be viewed as investments in brain health, not simply strategies for changing appearance or body weight.
5- We still need randomized trials to establish whether treating obesity actually prevents dementia, but the opportunity to improve metabolic and vascular health is already in front of us.
https://t.co/rkzpiV2zWu